Active substance
Sodium citrate dihydrate
- Health Canada 1
- UK MHRA 7
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP | 02377411 | 4 G / 100 ML | SOLUTION · EXTRACORPOREAL | BAXTER CORPORATION |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| BOOTS CYSTITIS RELIEF 4G GRANULES FOR ORAL SOLUTION | PL 12063/0045 | WRAFTON LABORATORIES LIMITED | GSL |
| CANESOASIS CYSTITIS RELIEF 4G GRANULES | PL 12063/0045 | WRAFTON LABORATORIES LIMITED | GSL |
| CARE CYSTITIS RELIEF 4G GRANULES FOR ORAL SOLUTION | PL 12063/0045 | WRAFTON LABORATORIES LIMITED | GSL |
| CYSTITIS RELIEF | PL 12063/0045 | WRAFTON LABORATORIES LIMITED | GSL |
| CYSTOCALM 4G GRANULES FOR ORAL SOLUTION | PL 12063/0045 | WRAFTON LABORATORIES LIMITED | GSL |
| SAINSBURYS HEALTHCARE CYSTITIS RELIEF 4G GRANULES FOR ORAL SOLUTION | PL 12063/0045 | WRAFTON LABORATORIES LIMITED | GSL |
| SODIUM CITRATE 0.3M ORAL SOLUTION | PLGB 48259/0096 | NORTHUMBRIA PHARMA LIMITED | POM |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.